IM Therapeutics
Biotechnology Research
299 Washington St
5 employees
- Employees
- 5
- Contacts
- 2
- Emails
- 2
- Phones
- 1
IM Therapeutics Overview
- Headquarters
- 299 Washington St
- Phone Number
- Available in AeroLeads
- Website
- imtherapeutics.com
- Industry
- Biotechnology Research
- Employees
- 5
- Founded
- 2015
- Funding
- 10.0M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About IM Therapeutics
IM Therapeutics is building an HLA-directed platform for new therapies. We have demonstrated early effectiveness in type 1 diabetes and are building a pipeline of targeted therapies across autoimmune diseases.
IM Therapeutics Contact Details
- People in AeroLeads
- 3
- With contact data
- 2
- Email contacts
- 2
- 66.7% coverage
- Phone contacts
- 1
- 33.3% coverage
IM Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Nandan Padukone | Innovation Leader, Biotech C-suite | Greater Boston, United States |
Email
Phone
|
| Tim Weber | Quality Assurance Specialist, Tutor | Westminster, Colorado, United States |
Email
|
| Peter Gottlieb | Professor at Barbara Davis | Englewood, Colorado, United States |
View
|
Employees by Management Level
Individual contributor
3 profiles
Compare Similar Companies to IM Therapeutics
Revolo Biotherapeutics
Biotechnology Research
CreaGen, Inc.
Biotechnology
Stelexis BioSciences, Inc.
Biotechnology
C2I Accelerator
Biotechnology Research
Thermalin Inc.
Biotechnology
The Lillylulu Foundation
Non-Profit Organizations
T1D Action
Public Health
Blue Gen Therapeutics Foundation
Biotechnology Research
Fekra Therapeutics
Biotechnology Research
LabGarden
Research Services